Join us for a Community Dinner: Understanding HYMPAVZI (marstacimab-hncq)

Join us for an educational session exploring a rebalancing treatment option for hemophilia.

You’ll hear:

• The science behind rebalancing therapy
• Clinical trial data
• Safety information
• Information on administration
• Shared decision-making tips for patients and caregivers

Speaker: Zuiho “Z” Taniguchi, Patient Navigator

Understanding a Rebalancing Therapy Option for Hemophilia: In this session, we’ll dive into a rebalancing treatment option. From how it works to clinical trial learnings, you’ll gain the latest information to help you or your loved ones understand this treatment option with confidence.

Thank you to Pfizer for your support!